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THE ROLE OF DELAYED HYPERSENSITIVITY IN 
BLASTOMYCOSIS OF MICE
CHAPTER I 
INTRODUCTION
In recent years there has been an increase of 
interest in delayed or cellular hypersensitivity. It is now 
known that delayed hypersensitivity plays a critical role in 
autoimmune diseases, transplantation immunity, and host 
defense against infectious disease. In general, cellular 
defense mechanisms are the major participants in host 
defense against those pathogens capable of intracellular 
survival and proliferation. This defense involves resis­
tance to a number of bacterial diseases, and may be 
extremely important in host defense against cancer.
It should be pointed out that there are types of 
infection in which humoral antibody is the predominant 
mediator of immunity. However patients with aggammaglobu- 
linemia, still have good immunity to many diseases (3I).
Delayed hypersensitivity is the result of a series 
of complex interactions between specialized cells involved 
in cell-mediated immunity. The primary cells involved are 
antigen-reactive lymphocytes and macrophages. The cells
1
2involved in delayed hypersensitivity do not have abundant 
endoplasmic reticulum, although they contain many ribosomes 
and other structures necessary for protein synthesis. The 
lymphocytes, upon contact with specific antigen, produce 
soluble médiaters which influence other cells. If contact 
with antigen occurs intradermally in an appropriately sen­
sitized individual, an inflammatory reaction develops which 
reaches its maximum in 24—48 hr. Histologically the initial 
cells to infiltrate a skin test site are polymorphonuclear 
leukocytes. The peak of this infiltration occurs 4-6 hr 
following antigen injection. At 8-12 hr after injection 
both lymphocytes and macrophages begin to infiltrate the 
site, and reach a maximum at 24-48 hr. Giant cells and 
epithelial cells may be observed in the site at this time 
and may persist for several days (3). This reaction con­
sists mainly of erythema and induration. It must be dif­
ferentiated from immediate hypersensitivity and arthus 
reactions, which occur within minutes if anaphylactic anti­
bodies are present or after two hours if precipitin anti­
bodies are present.
The type of immune response obtained in experi­
mental animals and probably man is dependent, in part, on 
the manner in which the host is exposed to the antigen. 
Injection of antigen by the intravenous route seldom induces 
delayed hypersensitivity but may induce antibody synthesis, 
primarily in the spleen (5)* The best induction of delayed
3hypersensitivity results from incorporation of antigen into 
complete or incomplete Freund's adjuvant (30) and its injec­
tion intradermally into the footpads, or subcutaneously, 
into experimental animals (1, 2, 7).
The development of delayed-type hypersensitivity 
has many characteristics which are similar to antibody- 
mediated responses; both are functions of lymphocytes, are 
specific for a given antigen, and are increased by restimu­
lation. There are however, some differences. A major 
breakthrough in the understanding of delayed hypersensi­
tivity occurred when Landsteiner and Chase (l4) reported 
that delayed-type hypersensitivities could be passively 
transferred with peritoneal exudate cells. More recently 
a unique difference in the reaction of antigen with cell- 
associated receptors was described. The specificity is 
apparently different from that described for humoral anti­
bodies. Studies using synthetic polypeptides substituted 
with a hapten have shown that the determinant necessary to 
elicit a delayed reaction is larger than that required to 
react with humoral antibodies (25)*
Although antibodies are produced by the host in 
response to foreign agents, in some diseases they are not 
involved in protection of the host. Studies with sera from 
animals containing antibodies to C. neoformans and 
H. capsulatum were unsuccessful in passive protection 
trials (I5i 20). In contrast transfer of protection was
4obtained by transferring cells. Although one—half of the 
Coccidioides-infected survivors and one third of the 
spherule vaccinated mice did not exhibit a footpad reaction, 
Kong et al. (13) have shown that transfer of spleens from 
immune to normal mice resulted in immunity to aerosolized 
challenge. In addition passive transfer of delayed sensi­
tivity to tuberculin was achieved by transfer of mouse 
spleen cell suspensions (l6).
Blastomyces dermatitidis is a dimorphic fungus 
which causes a chronic granulomatous and suppurative dis­
ease, thought to originate as a respiratory infection.
After establishment in the lungs, the organisms may dis­
seminate to other organs, causing a progressive disease 
which may be lethal. The lungs, bones, and skin are the 
predominate organs involved in the systemic form of the 
disease. Mild respiratory clinical forms of blastomycosis 
may occur (as in coccidioidomycosis and histoplasmosis) but 
their frequency has not been proved. Although delayed 
hypersensitivity in man seems to be a reliable index of 
previous exposure to dimorphic fungi, little is known of 
its relationship to protection. Most immunity in experi­
mental mycotic infections may be determined in experimental 
animals by noting increased survival after challenge with 
a lethal dose, inhibition of fungal dissemination, enhanced 
cellular responses, or delayed hypersensitivity. A critical 
test for host immunity is the prevention of infection after
5severe challenge, or an increased ability of the host to 
control the disease. Although severity of blastomycosis 
has been modified by prior infection, no data on fungal 
growth have been presented (11).
Patients with blastomycosis typically become hyper­
sensitive. The most extensively used technique to detect 
this state is the intradermal injection of ground mycelial 
particles, yeast cells, or blastomycin (21). Blastomycin 
is almost exclusively used because of its stability while 
in storage, and its solubility. Smith (28) showed that 
delayed hypersensitivity was critical to the prognosis in 
patients with blastomycosis. Patients with recent pul­
monary invasion or local skin lesions having a positive 
skin test and a negative complement fixation test (CF) had 
the best prognosis. Patients with more extensive infection 
with a positive skin test and a positive CF test in low 
titer responded to treatment better than those in which the 
skin test was negative and the CF test was positive with 
high titers.
Mice are susceptible to infection with derma- 
titidis and are often used for laboratory investigation and 
in clinical confirmation of suspected infection with this 
organism (6, 26, 27). Intraperitoneal inoculation of a 
saline suspension of the pathological material (to which 
antibiotics have been added if the specimen is sputum) 
usually results in many small abscesses in the liver, spleen
6and mesentery in 3-4 weeks. Because of the relative diffi­
culty of skin testing the mouse, delayed hypersensitivity 
in this animal may be detected systemically or by footpad 
inoculation. Salvin (23) and Box et al. (4) showed that 
mice could be experimentally induced to develop delayed 
hypersensitivity to H. capsulatum, a systemic fungal 
pathogen similar to JB. dermatitidis. Following intra­
venous injection of living or dead H. capsulatum into 
sensitized mice, 90% of the mice died in 48 hr.
In recent years an in vitro technique has been 
developed for the detection of delayed hypersensitivity.
This technique enables investigators to take advantage of 
the inhibition of macrophages that occurs when lymphocytes 
are stimulated by antigen to produce and release specific 
soluble inhibitors. Inhibition of cell migration was 
refined to give a reproducible and a quantitative test by 
George and Vaughan (10) in 1962. Peritoneal exudate cells 
(PE) cells have been most frequently employed in this test. 
It is quite sensitive and appears to be specific for delayed 
hypersensitivity (9). By culturing lymph node tissue from 
patients with a positive skin test to histoplasmin, Thor 
and Dray (29) were able to specifically inhibit the migra­
tion of human monocytes in the presence of 30 MS of histo­
plasmin per ml of medium.
The primary goal of this investigation was to deter­
mine the role of delayed hypersensitivity in blastomycosis
7of mice. We wanted to determine if mice that had delayed 
hypersensitivity to dermatitidis would be protected from 
the lethal effects of intraperitoneal challenge. We wished 
to investigate induction of delayed hypersensitivity in 
mice with killed yeast cells and with viable cells of
dermatitidis. We also wanted to determine the concen­
tration of yeast cells necessary for induction of delayed 
hypersensitivity and for footpad sensitivity tests.
Finally we sought to investigate two highly inbred mouse 
strains (C57BL/6J and CBA/J) for their value as experi­
mental animals in delayed hypersensitivity experiments.
CHAPTER II 
MATERIALS AND METHODS
Test animals;
Two-month-old C57BL/6J or CBA/J mice of both sexes 
were used. The mice were separated according to sex and 
given water and mouse chow a_d libitum.
Organism:
The yeast phase of Blastomyces dermatitidis (iso­
late 2k2) used in this study was obtained from the Univer­
sity of Oklahoma stock culture collection. Yeast cultures 
were maintained on brain heart infusion (BHl) agar slants 
at 37 C.
Determination of LD__:
 2£
To determine the 21 day intraperitoneal (ip) LD^^ 
for C57BL/6J mice, Blastomyces dermatitidis was grown on 
BHl agar slants for three days at 37 C. The cells were 
harvested by washing the slants with sterile physiological 
saline, collected with a sterile pipette, and placed in a 
sterile vaccine bottle. Hemocytometer counts were made to 
determine the number of cells/ml. The stock suspension of 
yeast cells was diluted to the desired concentration for
8
9injection. One-^tenth ml amounts of the diluted inoculum 
were spread on BHl agar plates for viability determinations. 
The plates were incubated at room temperature for three 
weeks; at this time the B^ . dermatitidis colonies were 
counted and recorded. Cells prepared in this manner were 
15-40% viable. Each mouse was injected ip with 0.5 ml of 
the appropriate cell concentration and the number of sur­
vival days was noted. Studies were made with 120 mice to 
determine the LD^q . Calculations were performed according 
to the method of Reed and Muench (17).
Footpad tests:
To detect delayed hypersensitivity in mice, footpad 
sensitivity tests were done according to the procedure of 
Youmans and Youmans (34). The footpad tests were performed 
by injecting the appropriate antigen concentration contained 
in a volume of 0.03 ml into the right or left hind footpad 
and a similar volume of sterile physiological saline into 
the opposite footpad. A 1 ml syringe with a 27 gauge needle 
was used for the injections. Unless otherwise specified 
the thickness of each footpad was measured with a calipers 
calibrated to measure in tenths of a mm ati 0, 6, 24, and 
48 hr after injection. The difference in thickness between 
the saline-injected and the antigen-injected foot was cal­
culated and used as a measure of the amount of swelling.
The average difference for all mice in the test group was 
calculated and considered the mean increase in footpad
10
thickness. Before footpad testing the mice in each group 
were individually marked by notching their ears for recog­
nition throughout the testing period.
preparation of merthiolate-killed dermatitidis yeast 
cells :
Yeast cells, prepared by the method of Restrepo- 
Moreno, and Schneidau (l8) were used in sensitization of 
mice with killed cells and in footpad sensitivity tests. 
Yeast phase cultures were prepared by inoculation of the 
flasks with 5 ml of a stock suspension of yeast cells and 
incubation of the flasks at 35 C with constant agitation 
on a gyrorotary shaker (New Brunswick Scientific Co., New 
Jersey) at 103 rotation per minute. The stock suspension 
was prepared by transferring the growth from a 3-day old 
yeast culture on BHl agar slants to 200 ml of a tryptic soy 
broth dialysate medium and incubating for 1 week on the gy­
rorotary shaker at 35 C. After 1 week the cultures were 
checked for absence of contamination and uniformity oT 
growth. The cultures were pooled and merthiolate was added 
to a final concentration of 1:10,000, After 2 days at 3 C 
the cells were separated by centrifugation at 1500 rpm for 
15 minutes and stored at 5 C in 1:10,000 merthiolate. In 
all experiments the cells were washed 3 times in sterile 
physiological saline before use.
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Dry-weight determination of killed yeast cells;
Dry-weight determinations of killed dermatitidis 
yeast cells were made to standardize the inoculum. A stock 
suspension of merthiolate-killed yeast cells was washed by 
centrifugation in 50 ml graduated glass centrifuge tubes 
3 times at 1500 rpm for 15 minutes. The packed cells were 
resuspended to a 15% suspension in sterile distilled water. 
One ml of this suspension was placed in each of 6 tared 
weighing bottles. The bottles were placed in a drying oven 
(Fisher Isotemp) at 100 C for 1 hr, cooled, and reweighed 
until a constant weight was obtained, at which time the 
weight of the cells was recorded. The average dry weight 
equivalent per ml of packed wet cells was calculated. 
Aliquots from a stock suspension of killed cells were used 
for dry weight determinations, sensitization experiments 
and for preparation of cells used in the footpad tests.
For inoculation, cells were suspended in sterile physio­
logical saline (0.85% NaCl). The yeast cell concentration 
referred to in experiments are based on the dry weight 
equivalent of packed wet cells. Emulsion of P-BSA or 
killed determatitidis yeast cells with incomplete 
Freund's adjuvant ;
An incomplete Freund's adjuvant-yeast-cell emulsion 
was prepared to determine if a delayed-type hypersensitive 
response could be produced in mice with killed cells. The 
emulsion was prepared by continuous grinding, and 1 volume
12
of a suspension of killed cells (35 or l40 mg yeast cells/ 
ml) was added a drop at a time into a mortar containing a 
mixture of 5 parts of marcole 52 (Humble Oil and Refining 
Co.) and 1 part Arlacel A (Hill Top Research Inc., Miami- 
ville, Ohio). After all the cell suspension had been 
added, further émulsification was carried out by passing 
the material through an l8 gauge needle until the emulsion 
formed discrete drops on the surface of water. For sensi­
tization each mouse was injected sc with 0.1 ml of this 
emulsion; this amount contained the equivalent of 2 mg of 
dry yeast cells,.
Picryl BSA-incomplete adjuvant emulsion was prepared 
in a similar manner except that a solution containing either 
0.35 or 1.75 mg of P-BSA was added to the marcole 52 and 
Arlacel A.
Inoculation of mice with picryl bovine serum albumin:
To determine if delayed hypersensitivity could be 
induced to a protein antigen in C57BL/6J or CBA/J mice, a 
protein-hapten conjugate was used. The protein was BSA 
(Fraction V, Pent ex) modified by conjugation with picryl 
chloride (Eastman Organic Chemicals) following the pro­
cedure of Cell and Benacerraf (2). Seventy—five C57 mice 
were placed in 3 main groups. Twenty-five mice (5 per sub­
group) in one group each received 2 subcutaneous (sc) 
injections in the inguinal region of 5 )ug/0.1 ml of P-BSA 
emulsified in incomplete Freund's adjuvant. A second group
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emulsified in incomplete Freund's adjuvant. A second group
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of 25 mice received 25 pg/0.1 ml in a similar manner. 
Twenty—five uninoculated mice (5 per subgroup) served as 
controls. Five mice from each P-BSA—treated group and 
5 control mice were tested for footpad sensitivity to 50 ug 
of BSA on days 5, 15, 25, 351 and 40. A 1 ml syringe and 
a 25 gauge needle were used to make the injections. In a 
similar manner 10 CBA/J mice were inoculated and tested for 
footpad sensitivity at 15 and 35 days following initial 
injection. Ten CBA/J mice were used as controls.
Inoculation of mice with killed yeast cells:
To determine the time after vaccination with 
dermatitidis that delayed hypersensitivity could be 
detected by footpad inoculation and the most effective con­
centration of yeast cells to use for footpad sensitivity,
60 CS7 mice were separated into 2 groups. The first group 
consisted of 30 (5 per subgroup); all the mice in this 
group received 2 sc injections of merthiolate-killed yeast 
cells emulsified in incomplete Freund's adjuvant. The 
injections contained 2 mg of yeast cells/0.1 ml of emulsion 
and were given on day 0 and day 7. A 1 ml syringe with a 
25 gauge needle was used for making the injections. The 
second group consisted of 30 uninoculated control mice (5 
per subgroup). Both sc-inoculâted mice and controls were 
tested for footpad sensitivity on days 5, 12, and 20. Two 
concentrations (40 or 50 jug) of killed B. dermatitidis
14
yeast cells were used for the detection of footpad sensi­
tivity.
At each test period 10 mice were used for sc 
inoculation. The right rear footpads of 5 were each in­
jected with 40 ng and those of the other 5 with 50 PS of 
yeast cells. The left footpads received an equal volume of 
sterile saline. The footpads of 10 control mice were each 
injected in a similar manner. Footpad measurements were 
recorded at 0, 6, 24, and 48 hr after injection and the 
mean increase in thickness was calculated.
Inoculation with viable yeast cells;
To investigate the ability of mice inoculated sc 
with viable cells to develop delayed hypersensitivity,
60 C57 mice were divided into 2 groups. The first group 
of 30 (5 per subgroup) received a single sc injection of 
viable B^. dermatitidis yeast cells. Viable cells used in 
this study were prepared as described for the studies.
The cells were introduced with a 1 ml syringe and a 25 gauge 
needle. The second group consisted of 30 uninoculated con­
trol mice (5 per subgroup). Both sc-inoculated and control 
mice were tested for footpad sensitivity on days 3» 6, 9,
12, 15» and l8. At each test period five sc-inoculated 
mice and 5 controls were used. The right rear footpad of 
each mouse in both groups was injected with 45 Mg of killed 
dermatitidis yeast cells. Footpad measurements were 
recorded at 0, 6, 24, and 48 hr and the mean increase in
15
thickness was calculated.
Protection tests:
To determine if sc inoculation of mice with viable 
cells of dermatitidis resulted in protection, 200 mice
were separated into 2 groups of 100 each. Fifty in each 
group were sc injected with 0.1 ml of a yeast cell suspen­
sion that contained 3.9 x 10^ cells/ml. Viable yeast cells 
for protection studies were prepared as described for 
studies. Fifty uninoculated mice served as controls.
Three days after sc injection 30 sc—inoculated mice and 
30 controls were intraperitoneally (ip) inoculated with
5
0.5 ml of a yeast cell suspension that contained 3-9 x 10 
cells/ml. Ten sc—inoculâted mice and 10 controls were given 
an ip injection of an equal number of killed cells. The 
mortality of each group was recorded daily for 30 days.
Ten sc—inoculated and 10 control mice were tested for foot­
pad sensitivity by injection of 45 pg of killed yeast 
cells. In a similar manner 60 mice were challenged with 
0.5 LD^Q on day 15 after sc inoculation. Mortality was 
observed and recorded daily for a 30 day period.
Migration inhibition test:
A study designed to determine if delayed hypersen­
sitivity could be detected by inhibition of migration of 
peritoneal exudate (PE) cells was undertaken. One hundred 
and twenty C57 mice were divided into 2 groups of 60 each.
l6
One group was injected sc with 0.1 ml of dermatitidis 
yeast cell suspension that contained 3*9 x 10^ cells/ml; 
the other 60 mice were controls. The procedure for obtain­
ing PE cells was basically that of Rowley and Whitsby (32). 
PE cells obtained by washing the peritoneal cavities of 
20 sc—injected mice with 2—3 ml of Hanks balanced salt 
solution were pooled and placed in sterile siliconized 
centrifuge tubes. PE cells from 20 control mice were ob­
tained and pooled in a similar manner. Control cells were 
maintained separately throughout the study. PE cells were 
centrifuged at 900 rpm for 5 minutes (PR-2, International 
Centrifuge), and resuspended in Eagles Minimal Essential 
Medium (MEM) (MEM-spinner base, Schwarz Bioresearch Inc.). 
This medium contained 15% calf serum (Grand Island Bio­
logical Co.), 85 units of penicillin, and 85 fig of strepto­
mycin per ml of medium. The cells were washed once by 
centrifugation in MEM before use.
Mouse macrophage migration inhibition studies were 
based on the methods outlined by Anacker and Yamamoto (33)» 
The packed cells were resuspended to a 10% suspension in 
MEM and drawn up in capillary tubes (1,1-1.2 mm internal 
diameter, Scientific Products). The capillaries were sealed 
on one end, placed in sterile tubes, and centrifuged for 
five minutes at 900 rpm. The capillaries were cut at the 
cell-fluid interphase and the piece containing the packed 
cells was attached to the bottom cover slip of a Sykes-Moore
17
tissue culture chamber (Bellco) with a small amount of 
sterile silicone. The chambers were assembled and filled 
with MEM with or without 30 ^g/ml of blastomycin (242) and 
incubated at 37 C for 24 hr. Earlier experiments had shown 
that this concentration of blastomycin did not inhibit 
normal cell migration. The areas of migration of the cells 
from the open end of the capillaries were magnified and 
projected on a grid which previously had been marked and
2
calibrated to measure the actual area of migration in mm . 
The % migration was calculated by dividing the area of 
migration of cells in the presence of 30 pg/ml of blasto­
mycin multiplied by 100, by the area of migration of cells 
in the absence of blastomycin.
Suspensions of peritoneal exudate cells were assayed 
for the types of cells present; they were washed twice in 
MEM and resuspended in normal mouse serum. Smears from the 
suspensions were then stained with Wright's stain.
CHAPTER III
RESULTS
Inoculation of mice with P-BSA;
C57BL/6J mice inoculated sc with 5 or 25 Mg of emul­
sified P-BSA were footpad tested with 50 |ig of BSA after 5,
15, 251 35» and 40 days. During the first 25 days sensi­
tivity was not detected (48 hr reading) after footpad 
testing in the sc-inoculated or control mice (figure 1 ).
At 35 and 40 days there was a considerable increase in the 
average 48 hr footpad thickness after testing in mice inocu­
lated with either concentration of P-BSA, but not in the 
controls. An increase in footpad thickness was also noted 
in these mice 24 hr after footpad testing. The maximum 
increase in footpad thickness was obtained 48 hr after the 
35 day footpad test in mice previously inoculated with 
5 |ig of P-BSA. At this time the mean increase in footpad 
thickness for these mice was 0.48 mm. At the 40 day foot­
pad test the mean 48 hr increase in footpad thickness for 
the mice inoculated with 5 Mg of P-BSA was O.38 mm. The mice 
inoculated sc with 25 Mg P-BSA responded to footpad testing 
in a similar manner but with a smaller 48 hr mean increase
18
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Figure 1: Results of footpad sensitivity tests in C57BL/6J
mice receiving picryl bovine serum albunlin subcutaneously. 
Arrows indicate the days that the inoculations were made. 
The 48 hr mean increase after footpad test was plotted.
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in footpad thickness at the 35 and 40 day footpad test 
periods.
The footpads of CBA/J mice inoculated with 25 MS 
of the P-BSA emulsion were not sensitive to injection with 
50 pg of BSA. No increase in footpad thickness at 48 hr 
after footpad testing was noted at either the 15 or 35 day 
test periods. These results showed that the CBA/J mice 
were not suitable for footpad testing; they were not a 
suitable animal for study of delayed hypersensitivity.
Thus only the C57BL/6J mice were used in subsequent studies.
Inoculation of mice with killed cells of B. dermatitidis:
C57BL/6J mice inoculated sc with 2 mg of a yeast- 
cell emulsion of JB, dermatitidis were footpad tested with 
40 or 50 Mg of killed yeast cells after 5, 12, and 20 days. 
As can be seen in figure 2, footpad injection with 40 or 
50 ug at 5 days did not stimulate a 48 hr increase in foot­
pad thickness of sc inoculated mice or control mice. How­
ever hyperreactivity at 48 hr to 50 pg was noted in sc 
inoculated mice at the 12 and 20 day test periods. The 
maximum 48 hr increase in footpad thickness occurred at the 
20 day test period when mice were footpad tested with 50 Mg< 
At this time the mean increase in footpad thickness for 
these mice was 0.48 mm, which was considerably larger than 
footpad thickness of control mice. The footpads of mice 
tested with 40 Mg were not larger 48 hr after injection 
than those of control mice at either the 12 or 20 day test
22
Figure 2: Results of footpad inoculation with killed yeast
cells of dermatitidis.
Arrows indicate the days that the subcutaneous inoculations 
were made. C57BL/6J mice were inoculated with 2 mg of 
killed yeast cells emulsified in incomplete Freund's adju­
vant. The 48 hr mean increase after footpad injection was 
plotted.
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periods. It was determined later however, that 45 #g of 
killed cells elicited a hypersensitive response in sensi­
tized mice but did not elicit a response in normal mice. 
Therefore 45 pg was used as the footpad testing concentra­
tion of killed yeast cells in future experiments. Addi­
tional experiments have shown that 5 or 25 pg of killed 
cells do not elicit a footpad response in mice inoculated 
with the yeast cell emulsion and footpad tested in a 
similar manner. Other experiments have shown also that mice 
can be sensitized with either 0.5 or 2 mg of the yeast—cell 
emulsion. An increase was not seen in the 48 hr footpad 
thickness of control animals following footpad testing.
It was shown by results of this study that C57 mice can be 
sensitized to killed jB. dermatitidis yeast cells and the 
mice become hypersensitive by 12 days after sc inoculation.
Mice inoculated sc with 2 mg of emulsified yeast 
cells were footpad tested at 12 days with 50 pg of killed 
yeast cells. Following footpad injection their footpads 
were measured at 0, 6, 24, and 48 hr and the mean increase 
in footpad thickness was calculated for each period 
(table 1). At 6 hr following footpad injection the foot­
pad thickness of mice inoculated sc and controls was 
increased. By 24—48 hr however, the average footpad 
thickness of mice inoculated sc had increased while those 
of controls had decreased. For this reason, 48 hr was 
chosen as the best time to read the results of footpad
25
Table 1; Mean increase in footpad thickness of C57BL/6J 
mice following footpad injection with 50 >ig of killed cells 
12 days after sc inoculation with 2 mg of killed cells of 
dermatitidis emulsified in incomplete Freund's adjuvant.
Material
injected*
Mean increase (mm) 
Hours after injection
0 6 2k 48
killed cells 0 .06** 0.22 0.54 0.38
none 0.08 0.20 0.12 0.10
A 2 mg amount (dry weight equivalent) in incomplete 
Freund's adjuvant was injected sc on day 0 and ?•
Average of 5 mice.
26
sensitivity tests. In this paper all future references to 
the mean increase in footpad thickness will be referring 
to a 48 hr reading unless otherwise stated.
Inoculation of mice with viable yeast cells:
C57 mice were inoculated sc with viable yeast cells 
of dermatitidis and footpad tested with 45 |ig of killed 
yeast cells at 3, 6 , 9, 12, 15, and l8 days. Figure 3 
shows that no appreciable difference was noted at 3 days 
in the average footpad thickness of mice inoculated sc with 
viable cells or in control mice. Footpad sensitivity tests 
in mice inoculated sc at days 6 and 9 produced a moderate 
increase in footpad thickness. Two animals in the sc—inocu­
lated group had an increase in footpad thickness of 0.8 mm 
(one on day 6 and one on day 9). A marked increase in the 
mean footpad thickness of mice inoculated sc was noted at 
the 12, 15, and l8 day footpad test periods. The mean 
increase in footpad thickness of these mice on these test 
days was 0.48, O.58, and 0.40 mm, respectively. The 
increase in footpad thickness of all control animals foot­
pad tested on days 12, I5 , and I8 was less than 0.2 mm. 
However, 10 out of 15 mice inoculated sc and footpad tested 
on these days had a mean increase of 0.?2 mm (range-0.4-1.4) 
Mice inoculated sc with viable cells, and control 
animals were footpad tested with 45 jug of killed cells on 
day 15 after inoculation and measured at 6 hr and then 
daily for 7 days (figure 4). The maximum increase in
27
Figure 3: Results of footpad sensitivity tests for C57BL/6J
mice that received viable JB, dermatitidis yeast cells.
4
The single-sensitizing dose was 3.9 x 10 yeast cells
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Figure 4: Results of footpad sensitivity tests for mice
that received viable dermatitidis yeast cells.
The footpads of C57BL/6J mice inoculated subcutaneously 
and control mice were injected on day 15 and measured at 
6 hr and then daily for 7 days.
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footpad thickness occurred at 48 hr. After this the mean 
footpad thickness subsided slowly until it was almost back 
to that of the controls after 7 days.
Visible lesions developed at the site of inoculation 
in C57 mice approximately 9-12 days after sc inoculation of 
viable cells. The lesions were swollen and inflamed sub­
cutaneous areas which occasionally broke through the surface 
of the skin. Impression smears were made from the exudate 
material in this lesion. When the mice were autopsied at 
20 days after inoculation these smears revealed the charac­
teristic budding cells of dermatitidis. Its presence 
was confirmed by culture of the exudate on BHI agar plates. 
In most mice a large amount of exudate material was found 
just below the skin at the injection site.
From this study it was evident that mice inoculated 
sc with viable JB. dermatitidis cells became hypersensitive 
to footpad injection of killed yeast cells 12 days after 
inoculation. It was determined also that the maximum 
increase in footpad thickness of mice inoculated sc and 
footpad tested at 15 days with 45 |ig of killed cells 
occurred at 48 hr after footpad injection. In addition it 
was noted that mice were infected as evidenced by our 
ability to microscopically observe yeast cells in impres­
sion smears and to culture dermatitidis cells from the 
lesions at the injection site.
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Protection tests;
C57B1/6J mice inoculated sc with viable yeast cells 
and control mice were challenged ip with 0.5 of
jB. dermat itidis at 3 and 15 days following the sc inocula­
tion. This was just before and just after animals would 
have become hypersensitive. The 21 day for C57 mice
K
was 3*9 X 10 cells/ml. Additional C57 mice inoculated sc 
and control mice were tested for footpad sensitivity to 
45 pg of killed cells of dermatitidis and were given an 
ip inoculation of a concentration of killed cells equal to 
0.5 on day 3 and 15 following the sc inoculation. The
first deaths in control mice challenged at 3 days occurred 
at day 6 and 90% of the mice were dead by day 40 (figure 5). 
In mice inoculated sc and challenged with the same inoculum 
at 3 days, the first death was on day 11 and 96% of these 
mice were dead at 40 days.
Footpad-sensitivity tests performed on 10 mice 
inoculated sc and 10 control mice did not stimulate hyper­
sensitivity detectable by the footpad test 3 days after sc 
inoculation. Inoculation of mice ip with a concentration 
of killed cells equal to 0.5 did not result in death
or any signs of distress in either the mice inoculated sc 
or in the controls.
After the 15-day ip challenge (figure 6) the first
control mice died on day 11 and 93% were dead at 40 days.
After the 15^day ip challenge no mice inoculated sc died 
until day 20 and only 36% were dead at 40 days.
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Figure 3- Percent mortality in C57BL/6J mice inoculated
4
subcutaneously with 3*9 x 10 viable cells of IB. dermatitidis 
and intraperitoneally challenged 3 days later with 0.5 LD^^.
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Figure 6 : Percent mortality in C57BL/6J mice inoculated
subcutaneously with 3.9 x 10 viable cells of dermatitidis 
and intraperitoneally challenged 15 days later with 0.5
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Footpad tests performed on 10 control and 10 mice 
inoculated sc at 15 days showed that the sc inoculated mice 
had a marked increase in their mean footpad thickness while 
the footpad thickness of controls was not increased. The 
data in table 2 shows the mean footpad thickness of these 
mice tested with 45 Mg of killed cells 15 days after sc 
inoculation with viable cells. As can be seen in this 
table the mean footpad thickness of mice inoculated sc was 
much larger at 24-48 hr than those of control mice. The 
standard deviation in thickness of the yeast-cell injected 
foot of these mice was larger at 24 and 48 hr because the 
range in footpad thickness during this time was 1.9-4.0 mm. 
In contrast the range in footpad thickness of control mice 
during this time which was 2.1-2.4 mm. Controls and mice 
inoculated sc were challenged at 15 days with a concentra­
tion of killed cells equal to 0.5 LD^^. Neither mice inocu­
lated sc or control mice showed any signs of distress.
The results of this study show that sc inoculation 
of viable IB. dermatitidis cells, stimulates footpad sensi­
tivity to 45 Mg of killed cells and also induces signifi­
cant protection against lethal effects of viable derma­
titidis . Mice inoculated sc emd challenged at 3 days 
(before becoming hypersensitive) were not protected. Mice 
inoculated sc and challenged at 15 days (after becoming 
hypersensitive) were protected.
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Table 2. Footpad sensitivity of C57BL/6J mice to killed 
yeast cells of B^. dermatitidis 15 days after subcutaneous 
injection of 3.9 x 10^ viable cells.
Hours after 
f ootpad 
inoculation
Mean footpad thickness (mm) 
control sc injected
right* left right left
0 2.17^0.06** 2.08+0.07 2 .08+0.10 2.03+0.12
6 2.37i0.15 2.1510.11 2 .50+0.31 2.1310.16
24 2.29+0.18 2.12+0.09 2 .66+0.50 2 .0110.13
48 2.19i0.l4 2.07+0.10 2 .87+0.61 1.9910.11
*Right foot was injected with 45 Ug of killed yeast cells; 
the left foot was injected with saline.
* *Average foot thickness of 10 mice plus the standard
d eviation.
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Inhibition of migration of peritoneal exudate cells:
Peritoneal exudate cells were obtained from mice
4
inoculated sc with 3*9 x 10 viable cells of JB. dermatitidis
and from control mice. The ability of these cells to
migrate in the presence of 30 pg of blastomycin was tested
on days 3, 15» and 20. No inhibition of PE cell migration
in the presence of 30 pg of blastomycin was noted at 3 days
when the cells were obtained from either mice inoculated sc
or from control mice (table 3)* At 15 and 20 days however,
PE cells obtained from mice inoculated sc were inhibited in
their migration 13 and 21%, respectively. PE cells from
control mice were not inhibited from migrating by 30 pg
blastomycin at either of these test days.
Table 4 presents data representing the actual area
of migration of the PE cells. The average migration of
normal cells in the absence of blastomycin, using the mean
2
migration for each test period, was 2.39^0.22 mm . The
average migration of normal cells in the presence of 30 pg
2
of blastomycin was 2.36i0.24 mm ; the average migration of
PE cells from animals inoculated sc with no blastomycin was
2 .15i0 .l6 mm ; and in the presence of 30 pg of blastomycin
2
it was 1.9110.23 nun . The standard deviation in migration
2
within a single test was usually less than 0.34 mm ; how-
2
ever, in one test a standard deviation of 0.54 mm was 
observed. This occurred at the 3-day test period with nor­
mal cells in the absence of blastomycin. PE cells from
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Table 3» Inhibition of peritoneal exudate cells obtained 
from C57BL/6J mice at various intervals after subcutaneous 
inoculation with viable JB, dermatitidis cells. Percent 
migration in the presence of 30 jug of blastomycin.
Days after injection 
of viable yeast cells
Percent migration of PE cells 
control* sensitized
3 102** 105
15 97 87
20 98 79
* Controls consisted of PE cells obtained from normal 
mice.
*^Average percent migration from 4 capillaries repre­
senting 20 mice per group.
4i
Table 4. Migration of peritoneal exudate cells from ^ 
C 57BL/6J mice inoculated subcutaneously with 3-9 x 10 
viable cells of dermatitidis and control mice in the
presence or absence of 30 fig of blastomycin.
Days after sc 
injection of 
viable cells
Normal cells
blastomycin
Sensitized cells 
concentration
none 30 *ig none 30 )ig
3 1.92^0.54* 1.96*0.29 1.48*0.14 1 .56*0.11
15 2.90*0.24 2 .82*0.27 2,49*0,02 2 .19*0,34
20 2 .36^0.17 2.31*0.17 2,49*0,33 1.98^0.24
* Mean actual area of migration in mm2
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control C57 mice migrated 100% in the presence of 30 pg of 
blastomycin/ml. Other experiments had shown that 50 or 
100 pg of blastomycin did cause inhibition of PE cells from 
control mice.
Suspensions of peritoneal exudate cells from mice 
inoculated sc and normal mice contained about 60% macro­
phages, 30% lymphocytes, and 8% segmented cells. The 
majority of the sc— inoculated mice developed lesions at 
the injection site after 12-15 days, but did not develop 
a fatal infection during the time of observation.
PE cells from mice inoculated sc with viable cells 
of IB. dermatitidis are inhibited from migrating in the 
presence of 30 pg of blastomycin. This inhibition was 
noted at 15 and 20 days after sc inoculation of viable 
cells.
CHAPTER IV
DISCUSSION
Gell and Benacerraf (2) have shown that immnnica­
tion with hapten-carrying proteins in guinea pigs is fol­
lowed by the appearance of delayed hypersensitivity to the 
protein carrier. Antibodies against the carrier protein 
cannot be detected at this time although antibodies are 
present against the haptenic group. In addition, delayed 
hypersensitivity to the haptenic group was not detected in 
this study. It was our intention to minimize the immuno­
logical injury mediated by antibody reactions and to elicit 
only delayed hypersensitivity in the P-BSA sensitized mice. 
We found that delayed hypersensitivity to BSA in C57 mice 
was obtained 35 days after initial injection of P-BSA,
Our results agree with those of Crowle and Hu (?) who 
obtained the maximum response from mice exhibiting hyper­
sensitivity to BSA 3-4 weeks after treatment with BSA in 
incomplete Freund’s adjuvant. C57 mice inoculated with 
P—BSA were found to be hypersensitive to footpad inocula­
tion with BSA while CBA mice were not. For this reason the 
C 37 mice were used for footpad sensitization studies.
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The dermatitidis yeast cells used in this study 
induced delayed hypersensitivity. This sensitivity was 
detected by footpad inoculation with 45 or 50 fxs of killed 
yeast cells. Although an increase in footpad thickness 
could be observed when footpads of sensitized mice were 
challenged with 40 yug of yeast cells, this response was not 
larger than the control mice. Additional experiments had 
shown that 5 or 25 P-S of killed yeast cells were not suf­
ficient t'o elicit a delayed footpad response in sensitized 
mice. In our studies uninoculated mice responded with a 
mild inflammatory footpad response when injected with 50 pg 
of killed cells, but in most mice this reaction had subsided 
by 24 hr and the yeast—call injected foot appeared the same 
as the saline injected foot. Higher concentrations of 
yeast cells however, resulted in a toxic reaction which was 
characterized by redding, swelling, and induration which 
persisted for several days. The reaction resembled that 
observed when yeast cell concentrations not toxic for con­
trol mice were injected into the footpads of a sensitized 
mouse. Therefore it is necessary that uninoculated mice be 
used as controls in this type of investigation. The 
observation that IB. dermatitidis yeast cells contain a 
substance toxic for mice had previously been reported in 
the literature. Salvin (24) found that a saline extract 
of acetone-dried yeast cells of this organism contained a 
substance which was able to produce death in mice within 
48 hr.
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Footpad sensitivity to killed yeast cells was noted 
also following sc inoculation with viable cells. Develop­
ment of footpad sensitivity in these mice, tested every 
3 days for l8 days, occurred between the 9 and 12 day test 
periods; twelve days was the time a notable increase in 
footpad thickness was observed in mice inoculated with 
killed cells. Mice can be sensitized by sc inoculation with 
either living or dead yeast cells of B^ . dermatitidis and 
this sensitization occurs approximately 12 days after ini­
tial inoculation. These results support investigations of 
hypersensitivity using other systemic fungal pathogens. It 
has been determined that hypersensitivity to H. capsulatum 
is produced in mice 9-14 days after inoculation (4, 23) or 
to C_. immitis 15 days after injection with either spherules 
or coccidioidin contained in incomplete Freund's adju­
vant (13).
If the footpad sensitivity observed in this investi­
gation was due to delayed hypersensitivity, the migration 
of peritoneal exudate (PE) cells from sensitized mice should 
have been inhibited in the presence of blastomycin (242). 
Other investigators (12) have reported that the yeast phase 
and mycelial phase have common antigens, Blastomycin is a 
broth filtrate of the mycelial phase. In the present 
investigation evidence of delayed hypersensitivity was 
obtained when PE cells harvested from sc-inoculated mice 
were inhibited in their migration in the presence of 30 pg
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of blastomycin. Inhibition of PE cell migration from mice 
inoculated sc although not observed 3 days after inoculation 
was 13% by fifteen and 21% by twenty days after inoculation. 
Although this inhibition was moderate it was notable, since 
PE cells from control mice were not inhibited. This inhibi­
tion occurred at a time when mice inoculated in a similar 
manner had developed considerable footpad sensitivity to 
killed yeast cells. Additional experiments had shown that 
higher concentrations (50 or 100 pg) of blastomycin inhib­
ited the migration of PE cells from control mice 50-70%.
In our investigations it was noted that PE cells from 
uninoculated BALB/cJ mice were inhibited in their migration 
up to 50% in the presence of 30 pg of blastomycin; however 
100% migration of PE cells from these animals was obtained 
in the presence of 20 pg of blastomycin. These results 
point out that the blastomycin concentration used in mouse 
macrophage migrât ion-inhibition studies is critical and 
must be carefully controlled. The sensitivity of PE cells 
from different strains of highly inbred mice may reflect 
the animals ability to control experimental infection with 
B^ . dermatitidis. Thus normal cells from BALB/cJ mice were 
inhibited in their migration in the presence of 30 pg of 
blastomycin and normal cells of C57 mice were uninhibited 
in their migration at this same concentration. In summary 
tissues of mice from different highly inbred mouse strains 
exhibit differing degrees of sensitivity to migration- 
inhibition toxic factors of fungi.
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The results of the footpad tests and the PE inhibi­
tion studies have shown that these mice had acquired 
delayed hypersensitivity to dermatitidis after 12 days 
of immunization. The results of the protection showed that 
mice with delayed hypersensitivity were protected from a 
lethal challenge. When the mice inoculated sc and control 
mice were given a lethal challenge 3 days after sc inocula­
tion, there was no evidence of protection; however, by 
15 days the test mice had acquired a marked increase in 
their footpad size and were protected. It is evident that 
sc inoculation of viable dermatitidis yeast cells leads 
to the type of immune response that protects mice in this 
disease. We believe this response to be primarily a cell- 
mediated type of immunity.
In the present investigation we found that the 
manner of exposure of the host to the pathogen was critical 
in the production of delayed hypersensitivity. Subcutane­
ous inoculation of living or dead cells in adjuvant pro­
duced a far better state of delayed hypersensitivity than 
intraperitoneal inoculation. Mice inoculated intraperi- 
toneally with viable cells did not develop delayed hyper­
sensitivity as detected by footpad inoculation and were 
unable to control the progressive disease. In contrast, 
in this investigation mice inoculated sc with viable cells 
developed a considerable increase in footpad size and at 
autopsy 20 days after inoculation there was no evidence of 
dissemination.
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Roberts (19) compared the immune response of rabbits 
inoculated intravenously or intratracheally with viable 
cells of H, capsulatum. The results of this investigation 
show that the route of inoculation determines the type of 
response induced in rabbits to H. capsulatum. Seventy 
percent of the rabbits inoculated intratracheally with this 
organism, developed delayed hypersensitivity to histoplasmin, 
had few clinical symptoms, and the infection was not fatal. 
In contrast, only l4% of the rabbits inoculated intrave­
nously developed delayed hypersensitivity, most had severe 
clinical symptoms, and a number of these animals died.
These results imply that rabbits which have delayed hyper­
sensitivity to H. capsulatum are more protected from the 
progressive disease.
CHAPTER V
SUMMARY
C 57BL/6J mice rendered hypersensitive to J3. derma— 
titidis were protected from the lethal effects of a blasto- 
myces infection. This protection was observed following a 
lethal intraperitoneal (ip) challenge with viable cells 
15 days after subcutaneous (sc) inoculation of the mice 
with 3.9 X 10^ viable cells. It is important to note that 
no protection was observed in mice following a lethal ip 
inoculation of viable cells 3 days after receiving the sc 
inoculation. At 3 days after sc inoculation the mice had 
not become hypersensitive to killed yeast cells of derma— 
t itidis, as indicated by footpad testing, and were not pro­
tected; however by 15 days after the sc inoculation the 
mice were hypersensitive and were protected.
Delayed hypersensitivity was produced in C57 mice 
by subcutaneously inoculating them with two injections of 
either 0.5 or 2 mg of merthiolate-killed yeast cells in 
adjuvant or with a single injection of 3.9 x 10 viable 
cells. It was found that footpad sensitivity could be 
detected in these mice by footpad inoculation of 45 or 50 pg 
of killed yeast cells 12 days following the initial
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injection. Lower concentrations of killed cells failed to 
elicit an increase in footpad thickness 48 hr following 
footpad injection of sensitized mice.
The route of inoculation was critical in the induc­
tion of hypersensitivity. Subcutaneous inoculation of 
living cells or killed cells in adjuvant produced a far 
better state of delayed hypersensitivity than ip inocula­
tion.
Evidence of delayed hypersensitivity was noted also 
when peritoneal exudate cells from mice inoculated sc with 
viable cells were inhibited from migrating in the presence 
of 30 |ig of blastomycin. Peritoneal exudate cells from 
mice that received a single subcutaneous injection of viable 
cells were inhibited 13% at fifteen days and 21% at twenty 
days following injection. Peritoneal exudate cells from 
control mice were not inhibited in the presence of 30 iig 
of blastomycin at any test period.
C57BL/6J mice were found to be more suitable for 
footpad sensitization studies than CBA/J mice. No increase 
in footpad thickness in eithei* mouse àtrain was seen 
15 days after inoculation with 25 |ig of picryl bovine serum 
albumin, but by 35 days the footpads of the C57 mice inocu­
lated with 50 jug of BSA were notably larger at 48 hr than 
those of control mice. The footpads of CBA mice inoculated 
in a similar manner and tested at 35 days were not larger
than those of the control mice. Thus the 057 mice were 
used for studies of delayed hypersensitivity.
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PE cells from uninoculated BALB/cJ mice were inhib­
ited in their migration in the presence of 30 pg of blasto— 
mycin, but PE cells from C57 mice were not. Blastomycin 
concentrations used in mouse macrophage migration-inhibition 
studies is critical and also the mouse strain employed is 
of prime importance.
From the results of this study delayed hypersensi­
tivity or cellular immune factors play a major role in host 
protection against blastomycosis in mice.
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